# Delivery Order #15B10627F00000021

McKesson VA Pharmaceutical Prime Vendor Funding Order

**Buyer:** Federal Prison System / Bureau of Prisons

**Award Amount:** $35,081.92
**Ceiling:** $35,081.92

**Awarded:** October 01, 2026
**Period of Performance:** Oct 01, 2026 - Sep 30, 2027

**Identifier:** 15B10627F00000021
**NAICS:** 325412

This delivery order adds funding for the third option year of the Department of Veterans Affairs’ Pharmaceutical Prime Vendor Contract. McKesson Corporation, a pharmaceutical distributor, supports VA healthcare operations by supplying pharmaceuticals and related services, helping maintain access to medications for veterans. The order provides a limited first-quarter funding increment under the broader prime-vendor arrangement; it does not identify specific medicines or additional deliverables. The parent contract is a single-award indefinite-delivery vehicle awarded through full and open competition. It began in 2020 and is scheduled to run through 2028, with this option year covering an ongoing multi-year supply arrangement. The award record does not provide subcontractor, previous-order, or original-solicitation details. No separate acquisition program is identified.

### Description

MCKESSON MAT PROGRAM CONTACT #: 36W79720D0001 *OPTION YEAR 3* DOS: OCTOBER 1, 2026- SEPTEMBER 30, 2027 JUSTIFICATION: ADD FUNDING FOR QUARTER 1 (OCT 1- DEC 11)

[View original record](https://www.usaspending.gov/award/CONT_AWD_15B10627F00000021_1540_36W79720D0001_3600)
